Literature DB >> 14104973

ACETOHEXAMIDE IN TREATMENT OF DIABETES MELLITUS.

D A MONTGOMERY, G K RASTOGI, J A WEAVER.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS; BLOOD CHEMICAL ANALYSIS; CHLORPROPAMIDE; DIABETIC DIET; GASTROENTEROLOGY; GERIATRICS; GLUCOSE TOLERANCE TEST; LEUKOPENIA; MIDDLE AGE; TOLBUTAMIDE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14104973      PMCID： PMC1814067          DOI： 10.1136/bmj.1.5387.868

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Evaluation of duration of action and clinical effectiveness of acetohexamide.

Authors:  C WELLER; A DONESA; M LINDER
Journal:  Metabolism       Date:  1962-06       Impact factor: 8.694

2.  Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.

Authors:  B R BOSHELL; A S WILENSKY; J C BARRETT; J V ALMON
Journal:  Clin Pharmacol Ther       Date:  1962 Nov-Dec       Impact factor: 6.875

3.  The use of acetohexamide in the treatment of diabetes mellitus.

Authors:  H L DOBSON
Journal:  Metabolism       Date:  1962-12       Impact factor: 8.694

4.  Clinical evaluation of acetohexamide, a new sulfonylurea agent.

Authors:  J B FIELD; S A TYROLER
Journal:  Diabetes       Date:  1963 May-Jun       Impact factor: 9.461

5.  Cycloheptolamide and acetohexamide in therapy of diabetes mellitus.

Authors:  M C BALODIMOS; W H STIMSON; D C TANNER; J A REID; R H WILLIAMS
Journal:  Metabolism       Date:  1961-12       Impact factor: 8.694

6.  Long-term results in treatment of diabetes mellitus with the sulphonylureas.

Authors:  C K GORMAN; J A WEAVER
Journal:  Br Med J       Date:  1959-12-05

7.  Acetohexamide. Preliminary report on a new oral hypoglycemic agent.

Authors:  G E MAHA; W R KIRTLEY; M A ROOT; R C ANDERSON
Journal:  Diabetes       Date:  1962 Mar-Apr       Impact factor: 9.461

8.  Clinical evaluation of acetohexamide in treatment of diabetes.

Authors:  J A OWEN
Journal:  Metabolism       Date:  1962-05       Impact factor: 8.694
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.